ABEONA THERAPEUTICS INC. — Revenue by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/1d9d8e33-4312-4dfa-a3cc-c6fdbb03fe13/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $5.8M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-010413 |
| FY 2023 | $3.5M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-010190 |
| FY 2022 | $1.4M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009381 |
| FY 2021 | $3.0M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-008259 |
| FY 2020 | $10.0M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-006705 |
| FY 2018 | $3.0M | 2018-01-01 – 2018-12-31 | evidence 0001493152-20-004015 |
| FY 2017 | $837.0k | 2017-01-01 – 2017-12-31 | evidence 0001493152-20-004015 |
| FY 2016 | $889.0k | 2016-01-01 – 2016-12-31 | evidence 0001144204-19-014623 |
| FY 2015 | $1.0M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-091600 |
| FY 2014 | $925.0k | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-020126 |
| FY 2013 | $2.0M | 2013-01-01 – 2013-12-31 | evidence 0000318306-14-000006 |
| FY 2012 | $4.4M | 2012-01-01 – 2012-12-31 | evidence 0000318306-13-000004 |
| FY 2011 | $1.8M | 2011-01-01 – 2011-12-31 | evidence 0000318306-13-000004 |
| FY 2010 | $481.0k | 2010-01-01 – 2010-12-31 | evidence 0000318306-12-000020 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ABEONA THERAPEUTICS INC. — all facts · Net Income · Operating Income